Search Within

Aya Mohamed Haggiagi

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Advanced Practice Providers (4)
  2. Department of Medicine (4)
  3. Melanoma and Immunotherapeutics Service (4)
  4. Nursing (4)
  5. Solid Tumor Oncology Division (4)
  6. Biostatistics Service (1)

More Groups

People
  1. Bianca Santomasso (4)
  2. Jenessa Holder (4)
  3. Margaret Callahan (4)
  4. Rachna Malani (4)
  5. Samuel Briggs (4)
  6. Yelena Shames (4)

More People

Years
  1. 2019 (1)
  2. 2018 (2)
  3. 2017 (3)
Publications
  1. Journal for ImmunoTherapy of Cancer (1)
  2. Journal of Clinical Oncology (1)
  3. Leukemia and Lymphoma (1)
  4. Neuro-Oncology (1)
  5. Neuro-Oncology Practice (1)
  6. Neurology (1)
Publishers
  1. Oxford University Press (2)
  2. American Society of Clinical Oncology (1)
  3. Biomed Central Ltd (1)
  4. Lippincott Williams & Wilkins (1)
  5. Taylor & Francis Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Seizure response to temozolomide chemotherapy in patients with WHO grade II oligodendroglioma: A single-institution descriptive study
    Journal Article

    Haggiagi, A.; Avila, E. K.
    Neuro-Oncology Practice (2019)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade
    Meeting Abstract

    Santomasso, B.; Haggiagi, A.; Malani, R.; Maher, C. A.; Holder, J. N.; Shames, Y.; Wilcox, J.; Flynn, J.; Briggs, S.; Panageas, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Callahan, M.; Santomasso, B.
    Neurology (2018)

    Fulltext@MSK | Save
  • Neurotoxicity in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Santomasso, B.; Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Callahan, M.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Marginal zone dural lymphoma: The Memorial Sloan Kettering Cancer Center and University of Miami experiences
    Journal Article

    de la Fuente, M. I.; Haggiagi, A.; Moul, A.; Young, R. J.; Sidani, C.; Markoe, A.; Vega, F.; DeAngelis, L. M.; Lossos, I. S.
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save